 Miami, FL

LeJenue Research Associates PLLC

Arthritis

Psoriatic Arthritis

Systemic Lupus Erythematosus

Spondylitis

Musculoskeletal Diseases

Spondylarthritis

Joint Diseases

Psoriasis

Ankylosing Spondylitis

Upadacitinib

Adalimumab

Methotrexate

ABT-494

Elsubrutinib

AbbVie

Janssen (J&J Innovative Medicine)

condition

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

The purpose of this study is to evaluate how well nipocalimab works as compared to placebo in participants with moderate to severe Systemic lupus erythematosus (SLE, a long-term disease where the immune system mistakenly attacks its own healthy tissues, causing swelling and redness in various organs).

A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

LeJenue Research Associates PLLC | Miami, FL

Site insights

Work at this site?

Active trials

A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus (GARDENIA)

Trial sponsors